Project Information

Bid Title

iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project

Issuing Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Location

Maine

Published Date

Jun 11, 2026

Closing Date

Jun 23, 2026

Government Level

Federal

Status

Closed

Ref. #

NIH-NOI-26-PCA-NIA-01205

Original Source

Join to Access Full Details

Bid Inquiries

Join to Access Full Details

Bid Documents

Join to Access Full Details

Project Description

Follow

iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project

Active

Contract Opportunity

Notice ID

NIH-NOI-26-PCA-NIA-01205

Related Notice

Department/Ind. Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier

NATIONAL INSTITUTES OF HEALTH

Office

NATIONAL INSTITUTES OF HEALTH OLAO

General Information

• Contract Opportunity Type: Special Notice (Original)
• Original Published Date: Jun 11, 2026 10:52 am EDT
• Original Response Date: Jun 23, 2026 11:00 am EDT
• Inactive Policy: 15 days after response date
• Original Inactive Date: Jul 08, 2026
• Initiative:
  • None

Classification

• Original Set Aside:
• Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
• NAICS Code:
  • 325414 - Biological Product (except Diagnostic) Manufacturing
• Place of Performance:
  Bar Harbor , ME 04609
  USA

Description

SPECIAL NOTICE

NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT

Agency: Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Aging (NIA)

Office: Center for Alzheimer’s Disease and Related Dementias (CARD)

Notice Type: Special Notice

Notice Number: NIH-NOI-26-PCA-NIA-01205

Title: Notice of Intent to Sole Source – iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project

NAICS Code: 325414 – Biological Product (except Diagnostic) Manufacturing

PSC: 6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

Description

This is a notice of intent to award a sole source contract and is not a request for competitive quotations, proposals, or bids. The National Institute on Aging (NIA), Center for Alzheimer’s Disease and Related Dementias (CARD), intends to negotiate and award a firm-fixed-price contract to:

The Jackson Laboratory

600 Main Street

Bar Harbor, ME 04609

UEI: XR6LMXNKDJJ1

for iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project.

The anticipated contract will provide for the expansion, quality control, curation, biobanking, and distribution of up to 936 isogenic Alzheimer’s disease and related dementias (ADRD) induced pluripotent stem cell (iPSC) lines in support of the iPSC Neurodegenerative Disease Initiative (iNDI). The requirement includes:

• FA13.1J female SNV lines totaling 486 iPSC lines;


• 25 high-priority SNV trios across six additional iPSC lines totaling 450 iPSC lines;


• expansion and quality control in accordance with current iNDI protocols;


• product and web content creation for each iPSC line; and


• public distribution of cell lines through an established contractor-hosted website/platform.

The statutory authority for this acquisition is 41 U.S.C. 1901, as implemented by FAR 13.501(a)(1)(ii), based on the circumstances described in FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

The Government’s market research included review of the prior sources sought notice posted on SAM.gov under Notice ID 75N95025Q00209-SBSS, review of prior NIH awards for similar iNDI requirements, and review of commercially available information regarding potential sources. Based on that market research, The Jackson Laboratory is the only known source capable of providing the specific iNDI FA13.1J iPSC cell lines and associated expansion, quality control, curation, and distribution services required for this acquisition. The Jackson Laboratory also maintains the existing iNDI distribution infrastructure and has successfully performed prior related iNDI requirements for NIH.

Period of Performance

• Base Year: September 1, 2026 – August 31, 2027


• Option Year 1: September 1, 2027 – August 31, 2028


• Option Year 2: September 1, 2028 – August 31, 2029


• Option Year 3: September 1, 2029 – August 31, 2030

Place of Performance

The principal place of performance is the contractor’s facility.

Responses

This notice is not a solicitation. However, any responsible source that believes it can satisfy the Government’s requirement may submit a capability statement for the Government’s consideration. Capability statements shall clearly demonstrate the ability to provide:

1. the specific iNDI FA13.1J cell lines and associated iNDI lines required under this acquisition;


2. expansion and quality control in accordance with current iNDI protocols;


3. product and web content creation for each iPSC line;


4. public distribution through an established contractor-hosted platform; and


5. continuity sufficient to preserve comparability with existing iNDI resources and prior work.

Responses shall include, at a minimum:

• Company name


• UEI and CAGE Code, if applicable


• Business size and socioeconomic status


• Technical point of contact, including name, title, telephone number, and email address


• Narrative capability statement addressing the requirements above


• Relevant past performance information for similar efforts

Responses must be submitted electronically to the point(s) of contact below no later than June 23, 2026, 11:00 am EST. Responses received after the stated deadline may not be considered.

The Government will review all timely responses solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government will not be responsible for any costs incurred by respondents in preparing or submitting a response.

Point(s) of Contact

Primary Point of Contact: Linda Smith, Contracting Officer, linda.smith2@nih.gov

Secondary Point of Contact: Danielle Tines, Procurement Technician, danielle.tines@nih.gov

Attachments/Links

Contact Information

Contracting Office Address

• 6011 EXECUTIVE BLVD., SUITE 503L
• BETHESDA , MD 20892
• USA

Primary Point of Contact

• Linda Smith
• linda.smith2@nih.gov

Secondary Point of Contact

• Danielle Tines
• danielle.tines@nih.gov

History

• Jun 11, 2026 10:52 am EDTSpecial Notice (Original)

Commodity Codes

• FSC 65Medical, Dental, and Veterinary Equipment and Supplies

• NAICS 325414Biological Product (except Diagnostic) Manufacturing

* Disclaimer: Government BidHub provides information on bids, RFPs (Requests for Proposals), and RFQs (Requests for Qualifications) solely for convenience and informational purposes. This site is not an official public notice board. For official details, responses, or inquiries, please contact the relevant government agency directly.